Early Response to Therapeutic Plasma Exchange as a Prognostic Indicator in Pediatric Liver Transplant Recipients with Early Allograft Dysfunction
Pediatric Transplantation · 2026
DOI: 10.1111/petr.70395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Ibrahim Bingol und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Intensive Care, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Liver Transplantation, Plasma Exchange, Primary Graft Dysfunction. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Early allograft dysfunction (EAD) is a major determinant of morbidity and mortality after pediatric liver transplantation. Therapeutic plasma exchange (TPE) is increasingly used as supportive therapy, yet pediatric‐specific data remain limited. We aimed to determine whether early response to TPE predicts survival in pediatric liver transplant recipients with EAD.
Methods
In this retrospective study, 15 pediatric patients (0–18 years) who developed EAD after living donor liver transplantation and received TPE (2015–2023) were analyzed. EAD was defined by Olthoff criteria. Response was assessed within 72 h using predefined criteria. Patients were classified as responders ( n = 9) or non‐responders ( n = 6).
Results
Among 140 pediatric liver transplant recipients, 15 (10.7%) developed EAD. The median age was 13 months (IQR: 9.1–22.6), and 80% weighed ≤ 10 kg. Responders showed significant reductions in total bilirubin (17.0 to 9.0 mg/dL; p = 0.004), INR (3.0 to 1.5; p = 0.004), AST (2239 to 150 IU/L; p = 0.004), and ALT (2467 to 200 IU/L; p = 0.004); non‐responders showed no meaningful improvement. In‐hospital mortality occurred exclusively among non‐responders (83.3% vs. 0%; p = 0.001). Kaplan–Meier analysis revealed significant survival divergence (100% vs. 16.7% at day 45; log‐rank p = 0.0005). Pre‐TPE albumin was significantly lower in non‐responders (2.90 vs. 3.20 g/dL; p = 0.013), highlighting albumin as a potential early bedside screening parameter for identifying patients at higher risk of non‐response. One‐year overall survival was 66.7%.
Conclusions
Early response to TPE within 72 h strongly discriminates survival in pediatric EAD and may serve as a practical prognostic tool. Prospective multicenter studies are warranted to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Intensive Care, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
- Liver Transplantation Unit, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
- Department of Pediatrics, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
ORCID-Profile: Ibrahim Bingol, Tonguc Utku Yilmaz, Ozge Umur, Guntulu Sık, Eda Erdem, Remzi Emiroglu, Agop Citak
Zitieren
APA
Bingol, I., Yilmaz, T. U., Umur, O., Sık, G., Erdem, E., Emiroglu, R., & Citak, A. (2026). Early Response to Therapeutic Plasma Exchange as a Prognostic Indicator in Pediatric Liver Transplant Recipients with Early Allograft Dysfunction. Pediatric Transplantation. https://doi.org/10.1111/petr.70395
Vancouver
Bingol I, Yilmaz TU, Umur O, Sık G, Erdem E, Emiroglu R, et al. Early Response to Therapeutic Plasma Exchange as a Prognostic Indicator in Pediatric Liver Transplant Recipients with Early Allograft Dysfunction. Pediatric Transplantation. 2026. doi:10.1111/petr.70395
BibTeX
@article{Bingol2026,
author = {Bingol, Ibrahim and Yilmaz, Tonguc Utku and Umur, Ozge and Sık, Guntulu and Erdem, Eda and Emiroglu, Remzi and Citak, Agop},
title = {Early Response to Therapeutic Plasma Exchange as a Prognostic Indicator in Pediatric Liver Transplant Recipients with Early Allograft Dysfunction},
journal = {Pediatric Transplantation},
year = {2026},
doi = {10.1111/petr.70395}
}
EUVIMED